SCHEMBL428467

SCHEMBL428467

CCCC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.40
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
DUSP3 P51452 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 2/20 0.36
DGKA P23743 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FAAH O00519 2/20 0.35
LPAR1 Q92633 6/20 0.34
LPAR4 Q99677 2/20 0.34
LPAR5 Q9H1C0 2/20 0.34
LPAR2 Q9HBW0 2/20 0.34
LPAR3 Q9UBY5 2/20 0.34
ENPP2 Q13822 2/20 0.34
LPAR6 P43657 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4603636 1.00 MAPT (0.40) MAPTLMNAKDM4EDUSP3MEN1
Acetone SCHEMBL2803680 0.97 MAPT (0.38) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL21645267 0.89 MAPT (0.55) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL10795570 0.89 MAPT (0.55) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL21645312 0.88 MAPT (0.58) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL21645269 0.88 MAPT (0.58) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL539662 0.88 MAPT (0.58) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL21645279 0.88 MAPT (0.58) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL10765993 0.88 MAPT (0.58) MAPTLMNAKDM4EDUSP3MEN1
SCHEMBL6025493 0.88 MAPT (0.58) MAPTLMNAKDM4EDUSP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722864-B2 Glycosylated acetaminophen pro-drug analogs NuTek Pharma Ltd. (US) 2014-05-13 US disclosed
US-20120022012-A1 Glycosylated Acetaminophen Pro-Drug Analogs NuTek Pharma Ltd. 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022012-A1 Glycosylated Acetaminophen Pro-Drug Analogs UGT1A3, GCG, UGT1A1 MAPT 2243/4885LMNA 1396/4885KDM4E 4019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.